Cargando…

2452. Prevalence of Antimicrobial ReSistanCE iN BloodStream Infections in HOspitalized (BSI) PatieNts in BRazil (ASCENSION-BR): Preliminary Results of a Multicenter Study

BACKGROUND: Carbapenem-resistant Enterobacterales (CRE), P. aeruginosa (CRPA), A. baumannii (CRAB), methicillin-resistant S. aureus (MRSA) and vancomycin-resistant E. faecium (VRE) are major multidrug-resistant (MDR) bacteria causing healthcare-associated infections. There is no multicenter study ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Antochevis, Laura C, Barth, Afonso, Wilhelm, Camila, Carrilho, Cláudia, Arns, Beatriz, Guimarães, Luiz Felipe, Starling, Carlos E, Coelho, Andre, Mendes, Elisa, Rocha, Verônica, Martins, Amanda, Girão, Evelyne, Telles, João, Sudbrack, Letícia, Leão, Robson, Zavascki, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677869/
http://dx.doi.org/10.1093/ofid/ofad500.2070
_version_ 1785150231562682368
author Antochevis, Laura C
Barth, Afonso
Wilhelm, Camila
Carrilho, Cláudia
Arns, Beatriz
Guimarães, Luiz Felipe
Starling, Carlos E
Coelho, Andre
Mendes, Elisa
Rocha, Verônica
Martins, Amanda
Girão, Evelyne
Telles, João
Sudbrack, Letícia
Leão, Robson
Zavascki, Alexandre
author_facet Antochevis, Laura C
Barth, Afonso
Wilhelm, Camila
Carrilho, Cláudia
Arns, Beatriz
Guimarães, Luiz Felipe
Starling, Carlos E
Coelho, Andre
Mendes, Elisa
Rocha, Verônica
Martins, Amanda
Girão, Evelyne
Telles, João
Sudbrack, Letícia
Leão, Robson
Zavascki, Alexandre
author_sort Antochevis, Laura C
collection PubMed
description BACKGROUND: Carbapenem-resistant Enterobacterales (CRE), P. aeruginosa (CRPA), A. baumannii (CRAB), methicillin-resistant S. aureus (MRSA) and vancomycin-resistant E. faecium (VRE) are major multidrug-resistant (MDR) bacteria causing healthcare-associated infections. There is no multicenter study addressing the prevalence of these MDR bacteria in Brazil. We report the preliminary results of the ongoing ASCENSION-BR study evaluating the prevalence of these microorganisms in BSI in hospitalized patients in this country. METHODS: This prospective multicenter study has been conducted in 13 hospitals distributed in 4 of 5 Brazilian regions. From 15th August to 31st April (to be finished on 14th August 2023), each hospital recruited patients for a period of up to 6 months. Adult patients hospitalized for at least 48h, with positive blood cultures with Enterobacterales, P. aeruginosa, A. baumannii, S. aureus and Enterococcus spp. were eligible. More than one BSI of the same patients were included if caused by a distinct bacteria. MDR isolates were sent to a central laboratory where isolates were re-identified by MALDI-TOF-MS. RESULTS: A total of 10 hospitals recruited patients for 6 months(m), 1 for 5m, and 2 for 1m. 1231 bacterias were isolated from 1091 BSI episodes (118 were polymicrobial), and 442 (35.9%) were MDR. Enterobacterales were the most common isolates in BSIs (659, 75.3%), followed by S. aureus (221, 18.0%), A. baumannii (113, 12.9%), Enterococcus spp. (135, 11.0%: 48 [35.6%] E. faecium and 84 [62.2%] E. faecalis) and P. aeruginosa (103, 8.4%). Among Enterobacterales, the most frequent species were K. pneumoniae (275, 41.7%), E. coli (126, 19.1) and Enterobacter spp. (69, 10.5%). A total of 224 (34.0% of Enterobacterales) BSIs were caused by CRE (155 [69.2%] K. pneumoniae, 27 [12.1%] Serratia marcescens, 15 [6,7%] Enterobacter spp., and 27 [12.1%] other 11 species. A total of 100 (88.5% of A. baumannii) isolates recovered in BSIs were CRAB and 38 (36.9% of P. aeruginosa) were CRPA. Among Gram positives, 50 (22.6% of SA) were MRSA, and VRE represented 93.3% of E. faecium and 3.3% of E. faecalis isolates. CONCLUSION: High prevalence of MDR in BSI, notably in A. baumannii, were found among hospitalized patients in Brazil. DISCLOSURES: João Telles, MD, PhD, MSD: Advisor/Consultant|MSD: Speaker|Pfizer: Advisor/Consultant|Pfizer: Speaker|União Química: Advisor/Consultant|União Química: Speaker Alexandre Zavascki, MD, PhD, Pfizer: Advisor/Consultant|Pfizer: Grant/Research Support
format Online
Article
Text
id pubmed-10677869
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106778692023-11-27 2452. Prevalence of Antimicrobial ReSistanCE iN BloodStream Infections in HOspitalized (BSI) PatieNts in BRazil (ASCENSION-BR): Preliminary Results of a Multicenter Study Antochevis, Laura C Barth, Afonso Wilhelm, Camila Carrilho, Cláudia Arns, Beatriz Guimarães, Luiz Felipe Starling, Carlos E Coelho, Andre Mendes, Elisa Rocha, Verônica Martins, Amanda Girão, Evelyne Telles, João Sudbrack, Letícia Leão, Robson Zavascki, Alexandre Open Forum Infect Dis Abstract BACKGROUND: Carbapenem-resistant Enterobacterales (CRE), P. aeruginosa (CRPA), A. baumannii (CRAB), methicillin-resistant S. aureus (MRSA) and vancomycin-resistant E. faecium (VRE) are major multidrug-resistant (MDR) bacteria causing healthcare-associated infections. There is no multicenter study addressing the prevalence of these MDR bacteria in Brazil. We report the preliminary results of the ongoing ASCENSION-BR study evaluating the prevalence of these microorganisms in BSI in hospitalized patients in this country. METHODS: This prospective multicenter study has been conducted in 13 hospitals distributed in 4 of 5 Brazilian regions. From 15th August to 31st April (to be finished on 14th August 2023), each hospital recruited patients for a period of up to 6 months. Adult patients hospitalized for at least 48h, with positive blood cultures with Enterobacterales, P. aeruginosa, A. baumannii, S. aureus and Enterococcus spp. were eligible. More than one BSI of the same patients were included if caused by a distinct bacteria. MDR isolates were sent to a central laboratory where isolates were re-identified by MALDI-TOF-MS. RESULTS: A total of 10 hospitals recruited patients for 6 months(m), 1 for 5m, and 2 for 1m. 1231 bacterias were isolated from 1091 BSI episodes (118 were polymicrobial), and 442 (35.9%) were MDR. Enterobacterales were the most common isolates in BSIs (659, 75.3%), followed by S. aureus (221, 18.0%), A. baumannii (113, 12.9%), Enterococcus spp. (135, 11.0%: 48 [35.6%] E. faecium and 84 [62.2%] E. faecalis) and P. aeruginosa (103, 8.4%). Among Enterobacterales, the most frequent species were K. pneumoniae (275, 41.7%), E. coli (126, 19.1) and Enterobacter spp. (69, 10.5%). A total of 224 (34.0% of Enterobacterales) BSIs were caused by CRE (155 [69.2%] K. pneumoniae, 27 [12.1%] Serratia marcescens, 15 [6,7%] Enterobacter spp., and 27 [12.1%] other 11 species. A total of 100 (88.5% of A. baumannii) isolates recovered in BSIs were CRAB and 38 (36.9% of P. aeruginosa) were CRPA. Among Gram positives, 50 (22.6% of SA) were MRSA, and VRE represented 93.3% of E. faecium and 3.3% of E. faecalis isolates. CONCLUSION: High prevalence of MDR in BSI, notably in A. baumannii, were found among hospitalized patients in Brazil. DISCLOSURES: João Telles, MD, PhD, MSD: Advisor/Consultant|MSD: Speaker|Pfizer: Advisor/Consultant|Pfizer: Speaker|União Química: Advisor/Consultant|União Química: Speaker Alexandre Zavascki, MD, PhD, Pfizer: Advisor/Consultant|Pfizer: Grant/Research Support Oxford University Press 2023-11-27 /pmc/articles/PMC10677869/ http://dx.doi.org/10.1093/ofid/ofad500.2070 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Antochevis, Laura C
Barth, Afonso
Wilhelm, Camila
Carrilho, Cláudia
Arns, Beatriz
Guimarães, Luiz Felipe
Starling, Carlos E
Coelho, Andre
Mendes, Elisa
Rocha, Verônica
Martins, Amanda
Girão, Evelyne
Telles, João
Sudbrack, Letícia
Leão, Robson
Zavascki, Alexandre
2452. Prevalence of Antimicrobial ReSistanCE iN BloodStream Infections in HOspitalized (BSI) PatieNts in BRazil (ASCENSION-BR): Preliminary Results of a Multicenter Study
title 2452. Prevalence of Antimicrobial ReSistanCE iN BloodStream Infections in HOspitalized (BSI) PatieNts in BRazil (ASCENSION-BR): Preliminary Results of a Multicenter Study
title_full 2452. Prevalence of Antimicrobial ReSistanCE iN BloodStream Infections in HOspitalized (BSI) PatieNts in BRazil (ASCENSION-BR): Preliminary Results of a Multicenter Study
title_fullStr 2452. Prevalence of Antimicrobial ReSistanCE iN BloodStream Infections in HOspitalized (BSI) PatieNts in BRazil (ASCENSION-BR): Preliminary Results of a Multicenter Study
title_full_unstemmed 2452. Prevalence of Antimicrobial ReSistanCE iN BloodStream Infections in HOspitalized (BSI) PatieNts in BRazil (ASCENSION-BR): Preliminary Results of a Multicenter Study
title_short 2452. Prevalence of Antimicrobial ReSistanCE iN BloodStream Infections in HOspitalized (BSI) PatieNts in BRazil (ASCENSION-BR): Preliminary Results of a Multicenter Study
title_sort 2452. prevalence of antimicrobial resistance in bloodstream infections in hospitalized (bsi) patients in brazil (ascension-br): preliminary results of a multicenter study
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677869/
http://dx.doi.org/10.1093/ofid/ofad500.2070
work_keys_str_mv AT antochevislaurac 2452prevalenceofantimicrobialresistanceinbloodstreaminfectionsinhospitalizedbsipatientsinbrazilascensionbrpreliminaryresultsofamulticenterstudy
AT barthafonso 2452prevalenceofantimicrobialresistanceinbloodstreaminfectionsinhospitalizedbsipatientsinbrazilascensionbrpreliminaryresultsofamulticenterstudy
AT wilhelmcamila 2452prevalenceofantimicrobialresistanceinbloodstreaminfectionsinhospitalizedbsipatientsinbrazilascensionbrpreliminaryresultsofamulticenterstudy
AT carrilhoclaudia 2452prevalenceofantimicrobialresistanceinbloodstreaminfectionsinhospitalizedbsipatientsinbrazilascensionbrpreliminaryresultsofamulticenterstudy
AT arnsbeatriz 2452prevalenceofantimicrobialresistanceinbloodstreaminfectionsinhospitalizedbsipatientsinbrazilascensionbrpreliminaryresultsofamulticenterstudy
AT guimaraesluizfelipe 2452prevalenceofantimicrobialresistanceinbloodstreaminfectionsinhospitalizedbsipatientsinbrazilascensionbrpreliminaryresultsofamulticenterstudy
AT starlingcarlose 2452prevalenceofantimicrobialresistanceinbloodstreaminfectionsinhospitalizedbsipatientsinbrazilascensionbrpreliminaryresultsofamulticenterstudy
AT coelhoandre 2452prevalenceofantimicrobialresistanceinbloodstreaminfectionsinhospitalizedbsipatientsinbrazilascensionbrpreliminaryresultsofamulticenterstudy
AT mendeselisa 2452prevalenceofantimicrobialresistanceinbloodstreaminfectionsinhospitalizedbsipatientsinbrazilascensionbrpreliminaryresultsofamulticenterstudy
AT rochaveronica 2452prevalenceofantimicrobialresistanceinbloodstreaminfectionsinhospitalizedbsipatientsinbrazilascensionbrpreliminaryresultsofamulticenterstudy
AT martinsamanda 2452prevalenceofantimicrobialresistanceinbloodstreaminfectionsinhospitalizedbsipatientsinbrazilascensionbrpreliminaryresultsofamulticenterstudy
AT giraoevelyne 2452prevalenceofantimicrobialresistanceinbloodstreaminfectionsinhospitalizedbsipatientsinbrazilascensionbrpreliminaryresultsofamulticenterstudy
AT tellesjoao 2452prevalenceofantimicrobialresistanceinbloodstreaminfectionsinhospitalizedbsipatientsinbrazilascensionbrpreliminaryresultsofamulticenterstudy
AT sudbrackleticia 2452prevalenceofantimicrobialresistanceinbloodstreaminfectionsinhospitalizedbsipatientsinbrazilascensionbrpreliminaryresultsofamulticenterstudy
AT leaorobson 2452prevalenceofantimicrobialresistanceinbloodstreaminfectionsinhospitalizedbsipatientsinbrazilascensionbrpreliminaryresultsofamulticenterstudy
AT zavasckialexandre 2452prevalenceofantimicrobialresistanceinbloodstreaminfectionsinhospitalizedbsipatientsinbrazilascensionbrpreliminaryresultsofamulticenterstudy